クープロプトーシス: 疾患におけるバイオマーカー,メカニズム,治療法
Shuhui Wang1, Jian Zhang1, Yanyan Zhou1
1Department of Basic Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Molecules (Basel, Switzerland)
|February 13, 2026
まとめ
新しい細胞死経路であるクプロポトーシスは,ミトコンドリアの過剰な銅の蓄積によって引き起こされます. このプロセスは,がん,神経変性,その他の疾患と関連しており,新たな治療目標を提供している.
科学分野:
- バイオケミストリー バイオケミストリー
- 細胞生物学 細胞生物学
- 病理学 パトロジー
背景:
- 銅のホメオスタシスは,細胞の機能に不可欠です.
- クプロポトーシス (cuproptosis) は,新たに特定されたプログラム細胞死メカニズムである.
- ミトコンドリアに過剰な銅が蓄積され,クプロプトーシスを引き起こす.
研究 の 目的:
- カプロプトーシスの分子メカニズムを見直す.
- 様々な疾患におけるクプロプトーシスの役割を調査する.
- カプロプトーシスの治療戦略を要約する.
主な方法:
- 過去4年間の研究に関する文献レビュー.
- 分子機構と信号伝達経路の分析.
- カプロプトーシスに対する治療介入の評価.
主要な成果:
- クープロプトーシスには,銅に依存したミトコンドリア機能障害とタンパク質の集積が含まれます.
- クープロプトーシスは,癌,神経変性疾患,代謝障害に関与しています.
- 治療戦略には,ケレーティング剤,イオンキャリア,ナノ医薬品,天然製品などがあります.
結論:
- クプロポトーシスは,重要な病理学的意味合いを持つ独特の細胞死経路を表しています.
- カプロプトーシスをターゲットにすることは,様々な疾患に対する潜在的な治療の機会を提供します.
- 天然製品は,治療のためのクプロプトーシスの調節に有望を示しています.
関連する概念動画
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
981
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
981
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
524
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
524
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
559
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
559
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
588
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
588
Reaction Mechanisms
31.2K
Chemical reactions often occur in a stepwise fashion, involving two or more distinct reactions taking place in a sequence. A balanced equation indicates the reacting species and the product species, but it reveals no details about how the reaction occurs at the molecular level. The reaction mechanism (or reaction path) provides details regarding the precise, step-by-step process by which a reaction occurs.
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
31.2K


